Menu

News Releases

Date Title  
Toggle Summary Allscripts Reports Third Quarter 2001 Results
CHICAGO, Oct. 25 /PRNewswire/ -- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX), the leading provider of point-of-care decision support tools for physicians, announced today its results for the three and nine month periods ended September 30, 2001.
Toggle Summary USC Care Medical Group Selects Allscripts to Provide e-Prescribing and Charge Capture for State-of-the-Art Clinic
CHICAGO, Oct. 18 /PRNewswire/ -- Allscripts Healthcare Solutions (Nasdaq: MDRX), the leading provider of point-of-care decision support tools for physicians, announced today that USC Care Medical Group, Inc. has selected Allscripts to provide its TouchWorks(TM) solutions, including Rx+,
Toggle Summary AstraZeneca Selects Physicians Interactive for e-Detailing Program
CHICAGO, Oct. 16 /PRNewswire/ -- Allscripts Healthcare Solutions (Nasdaq: MDRX) Physicians Interactive(TM) (PI) business unit, announced today that it will be providing interactive product education -- also known as e-Detailing(TM) -- to physicians on behalf of AstraZeneca (NYSE: AZN).
Toggle Summary Allscripts Announces Third Quarter 2001 Conference Call
CHICAGO, Oct. 11 /PRNewswire/ -- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) the leading provider of point-of-care decision support solutions for physicians, invites you to listen to a live broadcast of the Company's Third Quarter 2001 results conference call hosted by Glen Tullman,
Toggle Summary University Of Minnesota Physicians Selects Allscripts
CHICAGO, Oct. 10 /PRNewswire/ -- Allscripts Healthcare Solutions (Nasdaq: MDRX), the leading provider of point-of-care decision support tools for physicians, announced today that the University of Minnesota Physicians has chosen Allscripts to implement its TouchWorks(TM)suite of clinical
Toggle Summary Allscripts Revises Third Quarter Estimates
CHICAGO, Oct. 5 /PRNewswire/ -- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) today reported that, based on preliminary financial information, it expects third quarter revenues to be in the range of $16-17 million and cash loss per share to be in the range of $0.30-$0.35, excluding the